You asked, and we listened. One area of drug development we are frequently asked to cover is the use of IT in clinical research, development and commercialization. As a result, the FierceBiotech team spent the last two months researching the topic, so we could understand how to make meaningful contributions to the industry and provide a publication our readers would find relevant, timely, and most importantly, Fierce.
I'm now ready to share our new publication with our readers.
FierceBiotech IT launches via e-mail newsletter this Monday, May 4. As a current FierceBiotech subscriber, you're entitled to an easy one-click sign-up by clicking here. FierceBiotech IT will be published every Monday by e-mail, and FierceBiotechIT.com will be updated throughout the week as news breaks.
George Miller, former Editor-in-Chief of BioExecutive International, will head up our team's coverage and serve as Lead Editor of FierceBiotech IT. Industry insiders already know George is a very talented writer with a keen eye for the kind of high-quality, relevant news that FierceBiotech readers demand every day. If you have ideas or comments for George, he can be reached via e-mail at: [email protected].
Thanks for your feedback--it directly led to the launch of this publication.
Arsalan Arif
Publisher, FierceBiotech
PS: Click here for one-click sign-up to FierceBiotech IT. Your first newsletter will be delivered Monday.